HOMBACH ROBERT J.
SEC CIK 1496182 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EMBC | Embecta Corp. | Dir | 109.6K | $223.8K | — | 6 | 2022-04-01 | 2026-08-12 |
| SPTX | Seaport Therapeutics, Inc. | Dir | 13.0K | $235.8K | — | 1 | 2026-06-22 | 2026-06-22 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Dir | 49.4K | — | — | 5 | 2022-05-24 | 2026-06-02 |
| HSIC | Henry Schein | Dir | 5,421 | — | — | 2 | 2025-03-04 | 2026-03-06 |
| KMX | CARMAX INC | Dir | 7,766 | — | — | 1 | 2021-07-02 | 2021-07-02 |
Most active insiders at EMBC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | HOMBACH ROBERT J. | Dir | $223.8K | — |
| 2 | Kurdikar Devdatt | Pres, CEO, Dir | $140.9K | — |
| 3 | Mann Jeffrey Z | SVP, GC, Head Corp. Dev, Secy | $99.8K | — |
| 4 | Elguicze Jacob | SVP, CFO | $93.4K | — |
| 5 | Morris Milton Mayo | Dir | — | $37.0K |
| 6 | Roth Anthony M. | VP, CAO | — | — |
| 7 | Curtis Shaun | SVP, Gbl Manuf, Sup. Chain | — | — |
| 8 | Casner Jean | CHRO | — | — |
| 9 | Anderson Carrie L | Dir | — | — |
| 10 | Pomeroy Claire | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 10:45 | 2026-08-12 | EMBC | Embecta Corp. | HOMBACH ROBERT J. | Dir | P - Purchase | $4.97 | +45.0K | 109.6K | +70% | +$223.8K | |
| I | 2026-06-24 06:05 | 2026-06-22 | SPTX | Seaport Therapeutics, Inc. | HOMBACH ROBERT J. | Dir | P - Purchase | $18.14 | +13.0K | 13.0K | New | +$235.8K |
| 2026-06-04 18:06 | 2026-06-02 | BMRN | BIOMARIN PHARMACEUTICAL INC | HOMBACH ROBERT J. | Dir | A - Grant | $0.00 | +7,490 | 49.4K | +18% | $0 | |
| 2026-03-09 | 2026-03-06 | HSIC | Henry Schein | HOMBACH ROBERT J. | Dir | A - Grant | $0.00 | +2,577 | 5,421 | +91% | $0 | |
| 2026-02-13 | 2026-02-11 | EMBC | Embecta Corp. | HOMBACH ROBERT J. | Dir | A - Grant | $0.00 | +22.8K | 64.6K | +55% | $0 | |
| 2025-05-22 | 2025-05-20 | BMRN | BIOMARIN PHARMACEUTICAL INC | HOMBACH ROBERT J. | Dir | A - Grant | $0.00 | +6,650 | 41.9K | +19% | $0 | |
| 2025-03-06 | 2025-03-04 | HSIC | Henry Schein | HOMBACH ROBERT J. | Dir | A - Grant | $0.00 | +2,844 | 2,844 | New | $0 | |
| 2025-02-14 | 2025-02-12 | EMBC | Embecta Corp. | HOMBACH ROBERT J. | Dir | A - Grant | $0.00 | +13.8K | 39.7K | +53% | $0 | |
| 2024-05-23 | 2024-05-21 | BMRN | BIOMARIN PHARMACEUTICAL INC | HOMBACH ROBERT J. | Dir | A - Grant | $0.00 | +4,720 | 35.2K | +15% | $0 | |
| 2024-02-09 | 2024-02-07 | EMBC | Embecta Corp. | HOMBACH ROBERT J. | Dir | A - Grant | $0.00 | +11.5K | 24.9K | +85% | $0 | |
| 2023-05-24 | 2023-05-23 | BMRN | BIOMARIN PHARMACEUTICAL INC | HOMBACH ROBERT J. | Dir | A - Grant | $0.00 | +4,190 | 30.5K | +16% | $0 | |
| 2023-02-10 | 2023-02-09 | EMBC | Embecta Corp. | HOMBACH ROBERT J. | Dir | A - Grant | $0.00 | +6,979 | 13.1K | +114% | $0 | |
| 2022-05-26 | 2022-05-24 | BMRN | BIOMARIN PHARMACEUTICAL INC | HOMBACH ROBERT J. | Dir | A - Grant | $0.00 | +4,980 | 26.3K | +23% | $0 | |
| 2022-04-05 | 2022-04-01 | EMBC | Embecta Corp. | HOMBACH ROBERT J. | Dir | A - Grant | $0.00 | +6,024 | 6,024 | New | $0 | |
| 2021-07-07 | 2021-07-02 | KMX | CARMAX INC | HOMBACH ROBERT J. | Dir | A - Grant | $0.00 | +1,308 | 7,766 | +20% | $0 |
Purchase Sale Sale after option exercise All abbreviations